Goodwin advised the joint underwriters on the deal. NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading manufacturers and designers of high-tech electronic security devices,...
NAPCO Security Technologies’ $74 Million Offering
Genenta Science S.p.A.’s Initial Public Offering On Nasdaq
IN BRIEF: Emmet, Marvin & Martin, LLP, Giovannelli e Associati Studio Legale, Goodwin Procter, Loeb & Loeb LLP, Spada Partners, advised on the matter. Emmet, Marvin...
Genenta Science S.p.A.’s Initial Public Offering On Nasdaq
Goodwin Procter advised the underwriters on the deal. Genenta Science S.p.A.’s (Nasdaq: GNTA) announced its upsized initial public offering, making history as the first Italian biotech to...
Pear Therapeutics’ $1.6 Billion Business Combination with Thimble Point Acquisition Corp.
Goodwin Procter LLP advised Pear Therapeutics on the deal. Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose...
Alpha Healthcare Acquisition Corp.’s $ 1.1 Billion Business Combination With Humacyte, Inc.
Goodwin Procter LLP advised Alpha Healthcare Acquisition Corp. on the deal. Covington & Burling LLP advised Humacyte, Inc. on the deal.Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC)...